×
S&P 500   3,815.94 (-0.25%)
DOW   30,832.36 (-0.85%)
QQQ   283.95 (+0.65%)
AAPL   140.25 (+0.95%)
MSFT   259.61 (+0.01%)
META   165.59 (+3.47%)
GOOGL   2,241.97 (+3.09%)
AMZN   113.01 (+3.15%)
TSLA   688.40 (+0.97%)
NVDA   147.91 (+1.85%)
NIO   21.81 (+2.11%)
BABA   116.91 (+0.78%)
AMD   74.31 (+0.87%)
MU   55.86 (+4.12%)
CGC   2.65 (-5.69%)
T   20.96 (-1.64%)
GE   61.11 (-3.82%)
F   11.07 (-2.21%)
DIS   96.32 (+0.19%)
AMC   12.59 (-6.95%)
PFE   51.07 (-2.37%)
PYPL   73.63 (+3.12%)
NFLX   183.21 (+1.81%)
S&P 500   3,815.94 (-0.25%)
DOW   30,832.36 (-0.85%)
QQQ   283.95 (+0.65%)
AAPL   140.25 (+0.95%)
MSFT   259.61 (+0.01%)
META   165.59 (+3.47%)
GOOGL   2,241.97 (+3.09%)
AMZN   113.01 (+3.15%)
TSLA   688.40 (+0.97%)
NVDA   147.91 (+1.85%)
NIO   21.81 (+2.11%)
BABA   116.91 (+0.78%)
AMD   74.31 (+0.87%)
MU   55.86 (+4.12%)
CGC   2.65 (-5.69%)
T   20.96 (-1.64%)
GE   61.11 (-3.82%)
F   11.07 (-2.21%)
DIS   96.32 (+0.19%)
AMC   12.59 (-6.95%)
PFE   51.07 (-2.37%)
PYPL   73.63 (+3.12%)
NFLX   183.21 (+1.81%)
S&P 500   3,815.94 (-0.25%)
DOW   30,832.36 (-0.85%)
QQQ   283.95 (+0.65%)
AAPL   140.25 (+0.95%)
MSFT   259.61 (+0.01%)
META   165.59 (+3.47%)
GOOGL   2,241.97 (+3.09%)
AMZN   113.01 (+3.15%)
TSLA   688.40 (+0.97%)
NVDA   147.91 (+1.85%)
NIO   21.81 (+2.11%)
BABA   116.91 (+0.78%)
AMD   74.31 (+0.87%)
MU   55.86 (+4.12%)
CGC   2.65 (-5.69%)
T   20.96 (-1.64%)
GE   61.11 (-3.82%)
F   11.07 (-2.21%)
DIS   96.32 (+0.19%)
AMC   12.59 (-6.95%)
PFE   51.07 (-2.37%)
PYPL   73.63 (+3.12%)
NFLX   183.21 (+1.81%)
S&P 500   3,815.94 (-0.25%)
DOW   30,832.36 (-0.85%)
QQQ   283.95 (+0.65%)
AAPL   140.25 (+0.95%)
MSFT   259.61 (+0.01%)
META   165.59 (+3.47%)
GOOGL   2,241.97 (+3.09%)
AMZN   113.01 (+3.15%)
TSLA   688.40 (+0.97%)
NVDA   147.91 (+1.85%)
NIO   21.81 (+2.11%)
BABA   116.91 (+0.78%)
AMD   74.31 (+0.87%)
MU   55.86 (+4.12%)
CGC   2.65 (-5.69%)
T   20.96 (-1.64%)
GE   61.11 (-3.82%)
F   11.07 (-2.21%)
DIS   96.32 (+0.19%)
AMC   12.59 (-6.95%)
PFE   51.07 (-2.37%)
PYPL   73.63 (+3.12%)
NFLX   183.21 (+1.81%)
NASDAQ:ALIM

Alimera Sciences Earnings Date, Estimates & Call Transcripts (2022)

$5.46
-0.01 (-0.18%)
(As of 07/1/2022 03:59 PM ET)
Add
Compare
Today's Range
$5.46
$5.48
50-Day Range
$4.00
$6.15
52-Week Range
$3.94
$9.79
Volume
327 shs
Average Volume
9,483 shs
Market Capitalization
$38.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Earnings Summary

Upcoming
Earnings Date
Aug. 12Estimated
Actual EPS
(May. 9)
-$0.85 Missed By -$0.18
Consensus EPS
(May. 9)
-$0.67
Last Year's Q2 EPS
(4/27/2021)
-$0.63
Skip Charts & View Estimated and Actual Earnings Data

ALIM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALIM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Alimera Sciences Earnings Estimates

Current Year EPS Consensus Estimate: $-2.08 EPS
Next Year EPS Consensus Estimate: $-0.75 EPS

ALIM Earnings Date and Information

Alimera Sciences last issued its earnings results on May 9th, 2022. The biopharmaceutical company reported ($0.85) earnings per share for the quarter, missing the consensus estimate of ($0.67) by $0.18. The company had revenue of $11.90 million for the quarter, compared to analysts' expectations of $13 million. Alimera Sciences has generated ($1.01) earnings per share over the last year (($1.01) diluted earnings per share). Earnings for Alimera Sciences are expected to grow in the coming year, from ($2.08) to ($0.75) per share. Alimera Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 12th, 2022 based off prior year's report dates.

Alimera Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/12/2022
(Estimated)
        
5/9/2022Q1 2022($0.67)($0.85)($0.18)($0.85)$13.00 million$11.90 million    
2/24/2022Q4 2021($0.38)($0.59)($0.21)($0.59)$14.00 million$13.96 million    
10/27/20219/30/2021($0.52)($0.60)($0.08)($0.60)$12.30 million$12.15 million    
8/13/2021Q2 2021$1.25$0.76($0.49)$0.49$23.30 million$21.70 million
4/27/20213/31/2021($0.54)($0.63)($0.09)($0.63)$11.60 million$11.21 million  
2/23/202112/31/2020($0.04)($0.18)($0.14)($0.18)$13.00 million$13.77 million  
11/2/20209/30/2020($0.49)($0.12)+$0.37($0.12)$10.75 million$12.47 million    
7/29/20206/30/2020($2.14)($0.51)+$1.63($0.51)$2.30 million$10.04 million  
4/29/20203/31/2020($0.43)($0.24)+$0.19($0.24)$14.04 million$14.54 million  
2/26/202012/31/2019($0.37)$0.08+$0.45$0.08$14.50 million$17.35 million    
10/29/2019Q3 2019($0.60)($0.60)($0.04)$12.75 million$12.85 million  
7/29/20196/30/2019($0.60)($1.05)($0.45)($0.07)$12.97 million$10.86 million
4/29/2019Q1 2019($0.90)($0.60)+$0.30($0.04)$12.25 million$12.89 million
11/5/2018Q3($0.90)($0.75)+$0.15($0.49)$11.12 million$11.14 million  
7/30/2018Q2 2018($0.90)($0.8550)+$0.0450($0.06)$10.78 million$10.92 million  
5/3/2018Q1 2018($0.90)($1.20)($0.30)($0.05)$9.80 million$9.80 million
2/28/2018Q4 2017($0.45)($1.56)($1.11)($0.10)$9.60 million$9.14 million  
11/1/2017Q3 2017($0.75)($0.60)+$0.15$9.50 million$9.78 million
8/2/2017Q2 2017($0.75)($0.60)+$0.15($0.04)$10.20 million$10.40 million  
5/8/2017Q1 2017($1.20)($1.50)($0.30)($0.10)$8.80 million$6.62 million  
3/1/2017Q4 2016($1.05)($1.50)($0.45)($0.11)$10.60 million$10.70 million  
11/2/2016Q316($1.65)($2.40)($0.75)($0.14)$10.53 million$8.30 million
8/3/2016Q2($2.85)($2.55)+$0.30($0.19)$8.42 million$3.80 million
5/4/2016Q1($2.85)($3.30)($0.45)($0.19)$5.83 million$5.80 million
3/2/2016Q4 2015($3.45)($3.60)($0.15)($0.24)$5.82 million
11/5/2015Q315($3.30)($3.15)+$0.15($0.39)$6.96 million$6.90 million
8/10/2015Q215($3.30)($3.75)($0.45)($0.31)$6.49 million$5.80 million  
5/7/2015Q115($3.60)($4.05)($0.45)($0.32)$3.90 million$3.90 million
3/4/2015Q414($2.40)($4.20)($1.80)($0.33)$5.11 million$1.70 million
11/6/2014Q314($10.50)($3.30)+$7.20($0.29)$3.75 million$2.40 million
8/7/2014Q214($3.45)($2.25)+$1.20($0.18)$2.70 million$2.19 million
5/8/2014Q114($3.75)($3.00)+$0.75$0.18$1.15 million$2.08 million
2/27/2014Q4 2013($4.05)($3.60)+$0.45($0.01)$0.75 million$0.94 million  
11/11/2013Q3 2013($4.50)($3.60)+$0.90($0.44)$0.38 million$0.76 million
8/12/2013Q2 2013($3.45)($4.50)($1.05)$0.07$3.00 million$0.18 million
5/9/2013Q1 2013($4.05)($4.05)($0.10)  
3/21/2013Q4 2012($3.45)($2.55)+$0.90
11/7/2012Q312($2.85)($2.55)+$0.30
8/9/2012Q2 2012($2.85)($2.25)+$0.60($0.15)
5/11/2012Q1 2012($2.10)($2.10)($0.14)
3/8/2012($3.60)($2.85)+$0.75
11/3/2011($2.85)($3.15)($0.30)  
8/4/2011($2.70)($2.55)+$0.15  
5/5/2011($3.00)($2.25)+$0.75
2/10/2011($3.30)($3.00)+$0.30
11/4/2010Q3 2010($3.90)($3.00)+$0.90($0.20)
8/12/2010Q2 2010($3.90)($3.00)+$0.90($0.20)
6/3/2010Q1 2010($7.35)($35.25)($27.90)($4.82)












Alimera Sciences Earnings - Frequently Asked Questions

When is Alimera Sciences's earnings date?

Alimera Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 12th, 2022 based off last year's report dates. Learn more on ALIM's earnings history.

Did Alimera Sciences beat their earnings estimates last quarter?

In the previous quarter, Alimera Sciences (NASDAQ:ALIM) missed the analysts' consensus estimate of ($0.67) by $0.18 with a reported earnings per share (EPS) of ($0.85). Learn more on analysts' earnings estimate vs. ALIM's actual earnings.

How can I listen to Alimera Sciences's earnings conference call?

The conference call for Alimera Sciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Alimera Sciences's conference call transcript?

The conference call transcript for Alimera Sciences's latest earnings report can be read online. Read Transcript

How much revenue does Alimera Sciences generate each year?

Alimera Sciences (NASDAQ:ALIM) has a recorded annual revenue of $59.03 million.

How much profit does Alimera Sciences generate each year?

Alimera Sciences (NASDAQ:ALIM) has a recorded net income of -$4.37 million. ALIM has generated -$1.01 earnings per share over the last four quarters.

What is Alimera Sciences's EPS forecast for next year?

Alimera Sciences's earnings are expected to grow from ($2.08) per share to ($0.75) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:ALIM) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.